| Companies sponsors |
Merck Sharp & Dohme (sotatercept) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Blood Pressure UK |
| |
British Cardiovascular Society |
| |
Asthma and Lung UK |
| |
Cardiovascular Care Partnership |
| |
Circulation Foundation |
| |
Heart UK |
| |
Network of Sikh Organisations |
| |
Pulmonary Hypertension Association UK |
| |
Pumping Marvellous Foundation |
| |
South Asian Health Foundation |
| |
Specialised Healthcare Alliance |
| Professional groups |
British and Irish Hypertension Society |
| |
British Association for Nursing in Cardiovascular Care |
| |
British Geriatrics Society |
| |
British Heart Foundation |
| |
British Nuclear Cardiology Society |
| |
British Society for Haematology |
| |
British Society for Heart Failure |
| |
British Society of Cardiovascular Imaging |
| |
British Thoracic Society |
| |
National Heart and Lung Institute |
| |
Primary Care Cardiovascular Society |
| |
Royal College of Emergency Medicine |
| |
Royal College of General Practitioners |
| |
Royal College of Nursing |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal College of Surgeons |
| |
Royal Pharmaceutical Society |
| |
Royal Society of Medicine |
| |
Society for Cardiological Science and Technology |
| |
Society for Vascular Nurses |
| |
Society for Vascular Technology |
| |
UK Clinical Pharmacy Association |
| |
Vascular Society of Great Britain and Ireland |
| Associated public health groups |
Public Health Wales |
| |
UK Health Security Agency |
| Comparator companies |
ADVANZ Pharma (epoprostenol) |
| |
Amarox (sildenafil) |
| |
AOP Orphan (treprostinil) |
| |
Aspire Pharma (tadalafil) |
| |
Aurobindo Pharma (bosentan, sildenafil, tadalafil) |
| |
Bayer (iloprost) |
| |
Cipla EU (ambrisentan, bosentan, tadalafil) |
| |
Colonis Pharma (iloprost) |
| |
Crescent Pharma (sildenafil) |
| |
Dr. Reddy’s Laboratories (ambrisentan, bosentan, sildenafil, treprostinil) |
| |
Eli Lilly and Company (tadalafil) |
| |
GlaxoSmithKline (ambrisentan, epoprostenol) |
| |
Janssen-Cilag (macitentan, epoprostenol, selexipag) |
| |
Merck Sharp & Dohme (riociguat) |
| |
Mylan (ambrisentan, bosentan, sildenafil, tadalafil) |
| |
Ranbaxy (tadalafil, epoprostenol) |
| |
Rosemont Pharmaceutical (bumetanide, sildenafil) |
| |
Sandoz (sildenafil) |
| |
Sanofi (tadalafil) |
| |
Sigma Pharmaceuticals (sildenafil) |
| |
Sovereign Medical (tadalafil) |
| |
Teva Pharma (sildenafil) |
| |
The Boots Company (sildenafil) |
| |
Tillomed Laboratories (treprostinil) |
| |
Upjohn UK (sildenafil) |
| |
Zentiva (ambrisentan) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
Allied Health Professionals Federation |
| |
Board of Community Health Councils in Wales |
| |
British National Formulary |
| |
Care Quality Commission |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
National Association of Primary Care |
| |
National Pharmacy Association |
| |
NHS Confederation |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
British Society for Cardiovascular Research |
| |
Cardiac and Cardiology Research Dept, Barts |
| |
Circulation Foundation |
| |
Cochrane Hypertension Group |
| |
European Council for Cardiovascular Research |
| |
Genomics England |
| |
Heart Research UK |
| |
MRC Clinical Trials Unit |
| |
National Centre for Cardiovascular Preventions and Outcomes |
| |
National Institute for Health Research |
| |
Wellcome Trust |